News
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
3h
Barchart on MSNThis Blue-Chip Stock Is 20% Off Its Highs. Should You Buy the Dip?Pfizer (PFE), a global pharmaceutical giant that was once a pandemic darling, is now facing turbulence. Following a period of extraordinary vaccine-driven revenue, the company now faces a more ...
Research shows that COVID tends to spike twice annually — once in the winter and once in the summer, and, like past years, ...
A federal court dismissed a journalist’s claims against Pfizer executives and a member of the former Biden Administration for ...
An extremely painful sore throat, often now referred to as “razor blade throat”, is just one of the several symptoms of a new ...
Symptoms mirror Omicron’s, that is, fever, cough, fatigue, sore throat, and muscle aches. Though India’s Covid response ...
The most dominant COVID variant is LP.8.1, which at last count has made up 38% of cases, with Nimbus at 37%, variants XFG at ...
A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...
Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab ...
Coronavirus cases may surge in the coming weeks, as they have every summer since the pandemic began five years ago, experts ...
A newly distinguished University of New Mexico professor discusses her clinical research and advocacy around Long COVID.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results